Merck Starts To Suspend Worldwide Availability Of Tredaptive Reply

by • Policy & Ethics, Prevention, Epidemiology & Outcomes • Tags: , , , , , ,

In the wake of the negative HPS2-THRIVE study announced last month, Merck said today that it was beginning to suspend the worldwide availability of Tredaptive, its combination of extended-release niacin and laropiprant.

Click here to read the full story on Forbes.

 

About these ads

What do you think?

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out / Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out / Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out / Change )

Cancel

Connecting to %s